Business
TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014
TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\nTNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014\nPR Newswire\nORLANDO, Fla., Aug. 14, 2014\n\n\n\nORLANDO, Fla., Aug. 14, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) (\"we\" or the \"Company\") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is extending the record date of the dividend of Cytocom Inc., shares to all shareholders of the Company to September 30th, 2014. \n\nThe Company will pay out a dividend of one share of Cytocom Inc. for one share of the Company. Our shareholders as of the record date will continue to own shares in the Company in the same form and in the same quantity as of the record date. \n\nTo receive the Cytocom Inc. share dividend, all shareholders must surrender all existing share certificates to the Company's transfer agent.  There is no electronic transfer so shareholders must obtain certificates of the Company and turn them into our transfer agent.  If a shareholder turns its share certificate(s) into our transfer agent, our transfer agent will then send to such shareholder a Cytocom Inc. Certificate showing the ownership of Cytocom Inc. shares and will return the Company certificate(s) showing the ownership of Company shares owned on the record date.  \n\nReasons for the extension are as follows:\n\n\nWe have received requests from some US stockholders and Carricklee Consulting Ltd., on behalf of a number of major shareholders, to further extend the date of record of the Cytocom Inc. share dividend until the 30th of September 2014 (FINAL EXTENSION). This will enable any remaining shareholders who have not had sufficient time to exercise their warrant...